{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:23:13Z","timestamp":1787656993551,"version":"build-2736575974"},"reference-count":21,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,8,15]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>The Duffy-null phenotype is associated with fewer circulating blood neutrophils. This phenomenon, termed Duffy-null-associated neutrophil count (DANC), is common among individuals of African and Middle Eastern ancestry. Despite growing evidence that DANC does not increase the risk of infectious complications, oncology treatment protocols often rely on standardised absolute neutrophil count (ANC) thresholds to guide chemotherapy dosing and clinical trial candidacy. This reliance risks inappropriate dose reductions or treatment delays in patients with DANC. We present a patient with DANC and high-volume metastatic hormone-sensitive prostate cancer in whom lower neutrophil counts, found to be due to DANC, delayed initiation of chemotherapy and led to the use of granulocyte-colony stimulating factor (G-CSF). This case highlights the dilemma that DANC may lead clinicians to delay chemotherapy and\/or use G-CSF when neither may be needed. Future clinical studies are needed to develop DANC-specific thresholds for standard dose chemotherapy and G-CSF support.<\/jats:p>","DOI":"10.1136\/bcr-2026-273931","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:05:20Z","timestamp":1787655920000},"page":"e273931","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Re-evaluating absolute neutrophil count thresholds: Duffy-null-associated neutrophil count in cancer treatment"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-2611","authenticated-orcid":false,"given":"Michael","family":"Xu","sequence":"first","affiliation":[{"name":"Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R","family":"Wilson","sequence":"additional","affiliation":[{"name":"Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Moll","sequence":"additional","affiliation":[{"name":"Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C","family":"Miller","sequence":"additional","affiliation":[{"name":"Medicine, Division of Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C","family":"Fahey","sequence":"additional","affiliation":[{"name":"Medicine, Division of Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"2026082504050964000_19.8.e273931.1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/165188b0","article-title":"A New Human Blood Group","volume":"165","author":"Cutbush","year":"1950","journal-title":"Nature"},{"key":"2026082504050964000_19.8.e273931.2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/hdy.1950.31","article-title":"The Duffy blood group system","volume":"4","author":"CUTBUSH","year":"1950","journal-title":"Heredity (Edinb)"},{"key":"2026082504050964000_19.8.e273931.3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15730"},{"key":"2026082504050964000_19.8.e273931.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.07.005"},{"key":"2026082504050964000_19.8.e273931.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41439-018-0024-8","article-title":"Long-range haplotype analysis of the malaria parasite receptor gene ACKR1 in an East-African population","volume":"5","author":"Yin","year":"2018","journal-title":"Hum Genome Var"},{"key":"2026082504050964000_19.8.e273931.6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007679"},{"key":"2026082504050964000_19.8.e273931.7","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1265","article-title":"The global distribution of the Duffy blood group","volume":"2","author":"Howes","year":"2011","journal-title":"Nat Commun"},{"key":"2026082504050964000_19.8.e273931.8","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1093\/hmg\/ddaa208","article-title":"The Duffy-null genotype and risk of infection","volume":"29","author":"Legge","year":"2020","journal-title":"Hum Mol Genet"},{"key":"2026082504050964000_19.8.e273931.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194400","article-title":"Analyses of genome wide association data, cytokines, and gene expression in African-Americans with benign ethnic neutropenia","volume":"13","author":"Charles","year":"2018","journal-title":"PLoS One"},{"key":"2026082504050964000_19.8.e273931.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.09.018"},{"key":"2026082504050964000_19.8.e273931.11","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-1074","article-title":"Multicenter assessment of absolute neutrophil counts (ANC) and white blood cell counts (WBC) in healthy participants with the erythrocyte duffy null phenotype or genotype","volume":"146","author":"Merz","year":"2025","journal-title":"Blood"},{"key":"2026082504050964000_19.8.e273931.12","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/bloodadvances.2024014399","article-title":"Characterization of the phenotypic consequences of the Duffy-null genotype","volume":"9","author":"Hysong","year":"2025","journal-title":"Blood Adv"},{"key":"2026082504050964000_19.8.e273931.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.06.003"},{"key":"2026082504050964000_19.8.e273931.14","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1182\/bloodadvances.2024013453","article-title":"Febrile neutropenia in patients with Duffy-null-associated neutrophil counts and multiple myeloma or AL amyloidosis","volume":"8","author":"Abdallah","year":"2024","journal-title":"Blood Adv"},{"key":"2026082504050964000_19.8.e273931.15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.32475","article-title":"Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil Count","volume":"7","author":"Hibbs","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026082504050964000_19.8.e273931.16","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0166"},{"key":"2026082504050964000_19.8.e273931.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503747"},{"key":"2026082504050964000_19.8.e273931.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119115"},{"key":"2026082504050964000_19.8.e273931.19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bjh.20258","article-title":"The Duffy antigen: A narrative review of testing, epidemiology, neutrophil counts and clinical consequences","volume":"207","author":"Hibbs","year":"2025","journal-title":"Br J Haematol"},{"key":"2026082504050964000_19.8.e273931.20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00754"},{"key":"2026082504050964000_19.8.e273931.21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/bloodadvances.2024013945","article-title":"The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative","volume":"9","author":"Kuaban","year":"2025","journal-title":"Blood Adv"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-273931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:05:22Z","timestamp":1787655922000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-273931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,25]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bcr-2026-273931"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-273931","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}